These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 15364629)
1. Topical lidocaine patch therapy for myofascial pain. Dalpiaz AS; Lordon SP; Lipman AG J Pain Palliat Care Pharmacother; 2004; 18(3):15-34. PubMed ID: 15364629 [TBL] [Abstract][Full Text] [Related]
2. Myofascial pain response to topical lidocaine patch therapy: case report. Dalpiaz AS; Dodds TA J Pain Palliat Care Pharmacother; 2002; 16(1):99-104. PubMed ID: 14650453 [TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144 [TBL] [Abstract][Full Text] [Related]
4. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Galer BS; Sheldon E; Patel N; Codding C; Burch F; Gammaitoni AR Curr Med Res Opin; 2004 Sep; 20(9):1455-8. PubMed ID: 15383194 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a heated lidocaine/tetracaine topical patch for pain associated with myofascial trigger points: results of an open-label pilot study. Rauck R; Busch M; Marriott T Pain Pract; 2013 Sep; 13(7):533-8. PubMed ID: 23231060 [TBL] [Abstract][Full Text] [Related]
6. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Galer BS; Gammaitoni AR; Oleka N; Jensen MP; Argoff CE Curr Med Res Opin; 2004; 20 Suppl 2():S5-12. PubMed ID: 15563741 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595 [TBL] [Abstract][Full Text] [Related]
8. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Gammaitoni AR; Galer BS; Onawola R; Jensen MP; Argoff CE Curr Med Res Opin; 2004; 20 Suppl 2():S13-9. PubMed ID: 15563742 [TBL] [Abstract][Full Text] [Related]
9. Lidocaine patch 5 for carpal tunnel syndrome: how it compares with injections: a pilot study. Nalamachu S; Crockett RS; Mathur D J Fam Pract; 2006 Mar; 55(3):209-14. PubMed ID: 16510054 [TBL] [Abstract][Full Text] [Related]
10. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542 [TBL] [Abstract][Full Text] [Related]
11. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial. Katz NP; Gammaitoni AR; Davis MW; Dworkin RH; Pain Med; 2002 Dec; 3(4):324-32. PubMed ID: 15099237 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale. Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743 [TBL] [Abstract][Full Text] [Related]
13. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Herrmann DN; Barbano RL; Hart-Gouleau S; Pennella-Vaughan J; Dworkin RH Pain Med; 2005; 6(5):379-84. PubMed ID: 16266359 [TBL] [Abstract][Full Text] [Related]
14. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain. Ho KY; Huh BK; White WD; Yeh CC; Miller EJ Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia. Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274 [TBL] [Abstract][Full Text] [Related]
16. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. White WT; Patel N; Drass M; Nalamachu S Pain Med; 2003 Dec; 4(4):321-30. PubMed ID: 14750908 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Barbano RL; Herrmann DN; Hart-Gouleau S; Pennella-Vaughan J; Lodewick PA; Dworkin RH Arch Neurol; 2004 Jun; 61(6):914-8. PubMed ID: 15210530 [TBL] [Abstract][Full Text] [Related]
18. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Danielsson I; Torstensson T; Brodda-Jansen G; Bohm-Starke N Acta Obstet Gynecol Scand; 2006; 85(11):1360-7. PubMed ID: 17091418 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome]. Gül K; Onal SA Agri; 2009 Jul; 21(3):104-12. PubMed ID: 19780001 [TBL] [Abstract][Full Text] [Related]
20. Lidocaine 5% patch: an open-label naturalistic chronic pain treatment trial and prediction of response. Fishbain DA; Lewis JE; Cole B; Cutler B; Rosomoff HL; Rosomoff RS Pain Med; 2006; 7(2):135-42. PubMed ID: 16634726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]